McKinsey uses cookies to improve site functionality, provide you with a better browsing experience, and to enable our partners to advertise to you. Detailed information on the use of cookies on this Site, and how you can decline them, is provided in our Cookie Policy . By using this Site or clicking on OK, you consent to the use of cookies.

OK

Insights on Pharmaceuticals & Medical Products

Article

Winning against COVID-19: The implications for biopharma

– How companies act individually and collectively in the next few weeks and months will shape the outcome of the pandemic and the reputation of the biopharma industry for decades to come.
Report - McKinsey Global Institute

The Bio Revolution: Innovations transforming economies, societies, and our lives
– Advances in biological science could transform economies and societies, helping to tackle global challenges from climate change... to pandemics.
Article

COVID-19 implications for life sciences R&D: Recovery and the next normal
– COVID-19 has severely disrupted pharma and medtech R&D. Leaders should prepare along three horizons—safeguarding patients... and employees, adapting operations for a recovery, and building for the next normal.
Executive Briefing

COVID-19: Implications for business
– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.
Article

Pharma operations: The path to recovery and the next normal
– Pharma operations leaders have increased their focus on network risk management, agile and transparent operations, and shaping... the workforce of the future in the post-COVID-19 path to recovery.
Article

How COVID-19 is reshaping China’s medtech industry
– With COVID-19 accelerating the underlying trends in China’s medtech industry, new business models are likely to emerge.
Article - McKinsey Quarterly

How the Bio Revolution could transform the competitive landscape
– The disruption ahead extends well beyond healthcare. Are you prepared?
Article

Major challenges remain in COVID-19 testing
– There remain challenges and risk in considering “widespread testing” as the sole criterion for returning to work and... activities.
Article

How COVID-19 changes the game for biopharma in China
– Biopharmas should consider five areas as they deal with the crisis.

Special Collection

The Rise of Health Technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Article

Reimagining medtech for a COVID-19 world
– COVID-19 is creating unprecedented challenges for the medtech sector. Companies should consider stress-testing operating models... to strengthen crisis resilience and the longer-term path to recovery.
Article

COVID-19 and commercial pharma: Navigating an uneven recovery
– To respond best to the changes driven by the COVID-19 pandemic, pharma companies should consider reorienting their commercial... models to fit the needs of healthcare providers and patients better.
Article

Pharma operations: Creating the workforce of the future
– Reskilling employees to address talent gaps can help a company retain the bulk of its operations workers and empower them to take... advantage of a new world.
Article

Biopharma portfolio strategy in the era of cell and gene therapy
– Many biopharma companies are investing in cell and gene therapy, albeit cautiously, amid a nascent market. Understanding investment... opportunities and entry strategies will help guide their portfolio decisions.
Video

Accelerating progress in cancer care: Perspectives from six oncology leaders
– McKinsey recently spoke to industry leaders in oncology research and cancer care to ask about their vision of the future for oncology.
Article

The promise of digital therapeutics
– Investments in digital-therapeutics companies in the United States have grown, on average, by 40 percent a year over the past... seven years. What lies ahead for this fast-moving sector?
Article

Playing to win in oncology: Key capabilities for success
– Five key trends are driving growth in oncology. To be successful in oncology, a focus on capabilities is critical—both the ones... in place today and the ones needed to stay competitive.
Article

Leadership in a crisis: Responding to the coronavirus outbreak and future challenges
– For many executives, the coronavirus pandemic is a crisis unlike any other in recent times. Five leadership practices can help... you respond effectively. This article is available in Bahasa Indonesia titled: Kepemimpinan di masa krisis: Menghadapi wabah virus corona dan tantangan di masa depan.
Article

Unlocking the power of translational medicine
– By strengthening current translational medicine (TM) practices and preparing for advances, organizations could enhance the power... of TM and increase its influence on R&D productivity overall.
Article

Data and culture as stepping stones for Digital@Scale
– Pharma and medtech companies around the world have been building up their in-house capabilities in digital and advanced analytics,... but five challenges to implementing a digital strategy persist.
Article - McKinsey Quarterly

A game plan for quantum computing
– Thanks to technology advances, some companies may reap real gains from quantum computing within five years. What should you do... to prepare for this next big wave in computers?
Sorry, we couldn't find any results. Try removing some filters.
View more

More from this practice

McKinsey Cancer Center

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.

Related practice

Connect with our Pharmaceuticals & Medical Products Practice

Contact